NO307126B1 - Use of biologically active ureido derivatives for the manufacture of a medicament for use in the treatment of lentivirus-induced disease - Google Patents

Use of biologically active ureido derivatives for the manufacture of a medicament for use in the treatment of lentivirus-induced disease

Info

Publication number
NO307126B1
NO307126B1 NO944809A NO944809A NO307126B1 NO 307126 B1 NO307126 B1 NO 307126B1 NO 944809 A NO944809 A NO 944809A NO 944809 A NO944809 A NO 944809A NO 307126 B1 NO307126 B1 NO 307126B1
Authority
NO
Norway
Prior art keywords
lentivirus
medicament
manufacture
treatment
biologically active
Prior art date
Application number
NO944809A
Other languages
Norwegian (no)
Other versions
NO944809L (en
NO944809D0 (en
Inventor
Nicola Mongelli
Giovanni Biasoli
Maria Grandi
Marina Ciomei
Maria Cristina Geroni
Original Assignee
Pharmacia & Upjohn Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia & Upjohn Spa filed Critical Pharmacia & Upjohn Spa
Publication of NO944809L publication Critical patent/NO944809L/en
Publication of NO944809D0 publication Critical patent/NO944809D0/en
Publication of NO307126B1 publication Critical patent/NO307126B1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Virology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO944809A 1993-04-16 1994-12-12 Use of biologically active ureido derivatives for the manufacture of a medicament for use in the treatment of lentivirus-induced disease NO307126B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB939307948A GB9307948D0 (en) 1993-04-16 1993-04-16 Biologically active ureido derivatives useful in the treatment of lentivirus-induced disease
PCT/EP1994/000984 WO1994023718A1 (en) 1993-04-16 1994-03-29 Biologically active ureido derivatives useful in the treatment of lentivirus-induced disease

Publications (3)

Publication Number Publication Date
NO944809L NO944809L (en) 1994-12-12
NO944809D0 NO944809D0 (en) 1994-12-12
NO307126B1 true NO307126B1 (en) 2000-02-14

Family

ID=10733998

Family Applications (1)

Application Number Title Priority Date Filing Date
NO944809A NO307126B1 (en) 1993-04-16 1994-12-12 Use of biologically active ureido derivatives for the manufacture of a medicament for use in the treatment of lentivirus-induced disease

Country Status (15)

Country Link
EP (1) EP0646004A1 (en)
JP (1) JPH07508044A (en)
KR (1) KR950701812A (en)
AU (1) AU670194B2 (en)
CA (1) CA2137148A1 (en)
CZ (1) CZ282988B6 (en)
GB (1) GB9307948D0 (en)
HU (1) HU216834B (en)
IL (1) IL109235A (en)
NO (1) NO307126B1 (en)
PL (1) PL306798A1 (en)
RU (1) RU2142798C1 (en)
TW (1) TW308593B (en)
UA (1) UA42693C2 (en)
WO (1) WO1994023718A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9504065D0 (en) * 1995-03-01 1995-04-19 Pharmacia Spa Poly-pyrrolecarboxamidonaphthalenic acid derivatives
GB9602721D0 (en) * 1996-02-09 1996-04-10 Pharmacia Spa Biologically active ureido derivatives useful in the treatment of multiple sclerosis
GB2310207A (en) * 1996-02-15 1997-08-20 Pharmacia Spa Antiviral ureido derivatives of substituted heterocyclic compounds
GB9713733D0 (en) * 1997-06-27 1997-09-03 Pharmacia & Upjohn Spa Poly-branched polycarboxamido compounds
EP3381897A1 (en) 2017-03-27 2018-10-03 Leadiant Biosciences SA Derivatives of the disodium 2,2'-{carbonylbis[imino-3,1-phenylenecarbonylimino(1-methyl-1h-pyrrole-4,2-diyl)carbonylimino]}dinaphthalene-1,5-disulfonate salt and related compounds as heparanase inhibitors for the treatment of cancer

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9000644D0 (en) * 1990-01-11 1990-03-14 Erba Carlo Spa New ureido derivatives of poly-4-amino-2-carboxy-1-methyl compounds
CA2103665C (en) * 1991-02-06 2003-04-15 J. William Lown Oligopeptide antiretroviral agents

Also Published As

Publication number Publication date
UA42693C2 (en) 2001-11-15
NO944809L (en) 1994-12-12
EP0646004A1 (en) 1995-04-05
GB9307948D0 (en) 1993-06-02
IL109235A0 (en) 1994-07-31
HUT71838A (en) 1996-02-28
WO1994023718A1 (en) 1994-10-27
AU6537194A (en) 1994-11-08
PL306798A1 (en) 1995-04-18
CZ10795A3 (en) 1995-09-13
HU216834B (en) 1999-09-28
JPH07508044A (en) 1995-09-07
IL109235A (en) 1998-09-24
RU94046312A (en) 1996-10-20
KR950701812A (en) 1995-05-17
HU9500120D0 (en) 1995-03-28
RU2142798C1 (en) 1999-12-20
TW308593B (en) 1997-06-21
CZ282988B6 (en) 1997-12-17
CA2137148A1 (en) 1994-10-27
NO944809D0 (en) 1994-12-12
AU670194B2 (en) 1996-07-04

Similar Documents

Publication Publication Date Title
CY2007001I2 (en) MEDICINAL PREPARATION FOR USE IN THE TREATMENT OF DIABETES
NO981911D0 (en) Use of rhodanine derivatives for the manufacture of a medicament for the treatment of Alzheimer's disease
NO306235B1 (en) Use of a drug for the treatment of arthritis
NO306850B1 (en) Use of 5-halo-2-pyrimidinone deoxyribose or 5-halo-2-pyrimidinone in the manufacture of a medicament for the treatment of liver disease
BR9606607A (en) Compound method of improving the transport of a drug or other active method of making a drug compound using method of treating a disease and method of preparing a drug
KR950703566A (en) Thienodiazepine compound and its pharmaceutical use [THIENODIAZEPINE COMPOUND AND MEDICINAL USE THEREOF]
HUP9900028A3 (en) Pharmaceutically active quinazoline compounds, their production, use thereof and medicament containing them
IL130784A0 (en) Use of an anti-cd40l compound in the manufacture of a medicament for treating a patient with immune complex disease and pharmaceutical compositions containing the same
DE69326539D1 (en) CYTOTOXIC MEDICINE THERAPY
DE69430699D1 (en) DRUG DELIVERING STENTS
NO994165D0 (en) Use of descarboethoxyloratadine for the manufacture of a medicament for the treatment of urinary incontinence, travel sickness and dizziness
NO933000D0 (en) USE OF C1 INACTIVATOR FOR THE PREPARATION OF A MEDICINE FOR PROPHYLAXY AND TREATMENT OF CERTAIN DISEASES
RU94002133A (en) 6-CHLOR-5-FTOR-3- (2-TENOIL) -2-OXINDOL-1-CARBOXAMIDE AS AN ANALOGESIC AND ANIMATERATIVE MEDICATION
MX9101035A (en) BIOLOGICALLY ACTIVE QUINAZOLINONES AND THE PHARMACEUTICAL COMPOSITION CONTAINING THEM
ITMI940884A0 (en) TOPICAL MEDICINAL PRODUCT WITH HEALING ACTIVITY
HK1001375A1 (en) Use of acetylsalicylic acid in the manufacture of a drug for the treatment of skin injuries
ITMI911101A0 (en) ACTIVE DRUG IN AUTOIMMUNE DISEASES
NO307126B1 (en) Use of biologically active ureido derivatives for the manufacture of a medicament for use in the treatment of lentivirus-induced disease
FI973185A (en) Use of melatonin in the treatment of patients with drug dependence
LV12067A (en) Use of 17B-N-monosubstituted carbamoyl-4-aza-5α-androst-1-en-3-one in the manufacture of a medicament
KR950700737A (en) Medicine for the treatment of airways inflammation and airways hyperresponsiveness
NO974651D0 (en) Biologically active ureido derivatives useful in the treatment of multiple sclerosis
FI953622A (en) Use of ifenprodil and its diastereoisomers in the manufacture of a medicament useful in the treatment of peripheral neuropathic conditions and degenerative diseases of the central nervous system
FI953725A0 (en) Use of ornithine aminotransferase inhibitors in the manufacture of a medicament for the treatment of Alzheimer's disease
ITMI912652A0 (en) MEDICINAL PRODUCT WITH ANTIELASIC ACTIVITY

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees

Free format text: LAPSED IN SEPTEMBER 2002